Forum pracy nad projektem wskrzeszenia The Forge

[yoylqnqvwb]

Newly diagnosed type 2 diabetes,[link widoczny dla zalogowanych], insulin Comparison of two treatment methods


Second insulin peak and eat three meals a day can not match , the patient insulin before dinner , after dinner is easy because of hypoglycemia and can not arbitrarily increase ( under the transfer section 354 ) of Jiangsu University (Medicine Edition) Volume 14, Table 2 randomized controlled clinical groups 3 Comparison of fluoroquinolone antibiotics to discuss the fastest growing in recent years a class of antimicrobial agents, is currently listed in the domestic and foreign varieties have been more than 2O . Gatifloxacin and lomefloxacin are 2O 9O century after the era of the development of new varieties of gatifloxacin in its 6 and 8 -methoxy- fluoride structure , making it both the other antibacterial fluoroquinolone antibiotics Role, but also reduces light toxicity and resistance of gram- positive bacteria , and improve the security LlJ. Gatifloxacin antibacterial broad spectrum of gram-negative bacteria,[link widoczny dla zalogowanych], Gram -positive bacteria , Legionella, Chlamydia , mycoplasma , anaerobes (including Bacteroides and Clostridium ), and Mycobacterium and other pathogens are more Strong activity, but the weak central adverse reactions , no potential phototoxicity , there are obvious after-effects of antibiotic in vivo stability , tissue distribution is good. The tests showed that taking gatifloxacin 400mg,[link widoczny dla zalogowanych], 1 times / d,[link widoczny dla zalogowanych], and lomefloxacin 200 ~ 400mg, 2 times / d treatment group compared infectious diseases , gatifloxacin dosage group was significantly lower than lomefloxacin Star group, and only once a day medication , total effective rate was 93.48% and 9O. 00% ,[link widoczny dla zalogowanych], no significant difference between gatifloxacin less adverse reactions . In summary, gatifloxacin as a long-acting fluoroquinolone , easy to use, safe and effective in clinical bacterial infection . [
,],[